1. Home
  2. FSI vs NSRX Comparison

FSI vs NSRX Comparison

Compare FSI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$5.53

Market Cap

74.3M

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$5.80

Market Cap

52.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSI
NSRX
Founded
1991
2019
Country
Canada
Israel
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.3M
52.5M
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
FSI
NSRX
Price
$5.53
$5.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
56.9K
4.6K
Earning Date
11-14-2025
03-20-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$38,563,427.00
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$53.12
N/A
P/E Ratio
$39.44
N/A
Revenue Growth
0.18
N/A
52 Week Low
$3.46
$5.42
52 Week High
$11.48
$9.99

Technical Indicators

Market Signals
Indicator
FSI
NSRX
Relative Strength Index (RSI) 32.32 41.99
Support Level $5.65 $5.42
Resistance Level $6.02 $6.39
Average True Range (ATR) 0.29 0.32
MACD -0.01 -0.06
Stochastic Oscillator 6.43 21.35

Price Performance

Historical Comparison
FSI
NSRX

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: